0709 203000 - Nairobi 0709 983000 - Kilifi
0709 203000 - NRB 0709 983000 - Kilifi
0709 203000 - NRB | 0709 983000 - Kilifi

Back Home

Francis Ndungu/Wellcome Open Res


4 results

Kinetics of naturally induced binding and neutralising anti-SARS-CoV-2 antibody levels and potencies among SARS-CoV-2 infected Kenyans with diverse grades of COVID-19 severity: an observational study.Kimotho, J. Sein, Y. Sayed, S. Shah, R. Mwai, K. Saleh, M. Wanjiku, P. Mwacharo, J. Nyagwange, J. Karanja, H. Kutima, B. Gitonga, J. N. Mugo, D. Karanu, A. Moranga, L. Oluoch, V. Shah, J. Mutiso, J. Mburu, A. Nneka, Z. Betti, P. Usyu Mutinda, W. Abdi, A. I. Bejon, P. Ochola-Oyier, L. I. Warimwe, G. M. Nduati, E. W. Ndungu, F. M.
Wellcome Open Res, (2025). 8:350

TRUE-1: Trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults).Abouyannis, M. FitzGerald, R. Ngama, M. Mwangudzah, H. Nyambura, Y. K. Ngome, S. Riako, D. Babu, L. Lewa, F. Else, L. Dily Penchala, S. Orindi, B. Mumba, N. Kalama, B. Ndungu, F. M. Adetifa, I. Khoo, S. Lalloo, D. G. Casewell, N. R. Hamaluba, M.
Wellcome Open Res, (2022). 7:90

10-year longitudinal study of malaria in children: Insights into acquisition and maintenance of naturally acquired immunity.Addy, J. W. G. Bediako, Y. Ndungu, F. M. Valetta, J. J. Reid, A. J. Mwacharo, J. Ngoi, J. M. Wambua, J. Otieno, E. Musyoki, J. Said, K. Berriman, M. Marsh, K. Bejon, P. Recker, M. Langhorne, J.
Wellcome Open Res, (2022). 6:79

A seven-year study on the effect of the pre-erythrocytic malaria vaccine candidate RTS,S/AS01 (E) on blood stage immunity in young Kenyan children.Ndungu, F. M. Mwacharo, J. Wambua, J. Njuguna, P. Marsh, K. Drakeley, C. Bejon, P.
Wellcome Open Res, (2019). 4:42